URGN UroGen Pharma Ltd. - Ordinary Shares
$49,25
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$16–$50
98% of range
Analystenbewertung
STRONG BUY
14 analysts
Kursziel
$60
+22% upside
P/E (TTM)
—
ROE
154.4%
Nettogewinnmarge
-139.8%
URGN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$49.25
Marktkapitalisierung
$2.38B
P/E (TTM)
—
EPS (TTM)
—
Umsatz (TTM)
$110M
Dividendenrendite
—
ROE
154.4%
Verschuldungsgrad
-1.2
52W-Spanne
$16 – $50
URGN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$110M
2016-12-31
→
2025-12-31
EPS
—
Freier Cashflow
$-163M
2018-12-31
→
2025-12-31
Margen
-139.8%
2018-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
URGN
Peer-Median
P/S (TTM) (K/V (TTM))
21.7
10.7
P/B (K/B)
-22.6
4.2
EV / EBITDA
-18.8
—
Price / FCF (Kurs / FCF)
-14.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
URGN
Peer-Median
Gross Margin (Bruttogewinnmarge)
88.7%
62.1%
Operating Margin (Betriebsgewinnmarge)
-113.7%
—
Net Profit Margin (Nettogewinnmarge)
-139.8%
-257.8%
ROA
-63.1%
-28.7%
ROE
154.4%
-40.1%
ROIC
-746.5%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
URGN
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
-1.2
—
Current Ratio (Liquiditätsgrad)
4.0
5.5
Quick Ratio
4.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
URGN
Peer-Median
Revenue YoY (Umsatz YoY)
21.4%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
19.5%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
56.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
URGN
Peer-Median
URGN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 6 42,9%
- Kauf 6 42,9%
- Halten 2 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-18
Median
$59.00
Jetzt
$49.25
Tief
$48.00
Hoch
$75.00
Median-Ziel
$59.00
+19,8%
Mittelwert-Ziel
$60.00
+21,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.05%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.28 | $-0.29 | 0.01% |
| 31. März 2026 | $-0.47 | $-0.49 | 0.02% |
| 31. Dezember 2025 | $-0.54 | $-0.51 | -0.03% |
| 30. September 2025 | $-0.69 | $-0.71 | 0.02% |
| 30. Juni 2025 | $-1.05 | $-0.85 | -0.20% |
| 31. März 2025 | $-0.92 | $-0.82 | -0.10% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
| ENTX | $90M | 7.8 | -76.8% | -27235.7% | -75.4% | 0.00% |
| KMDA | — | — | — | — | — | — |
| CGEN | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $110M | $90M | $83M | $64M | $48M | $12M | $18.0K | $1M | $8M | |
| Cost of Revenue | $12M | $9M | $9M | $8M | $5M | $1M | · | $2M | $600.0K | |
| Gross Profit | $97M | $82M | $73M | $57M | $43M | $11M | $18.0K | $-675.0K | $8M | |
| R&D Expense | $67M | $57M | $46M | $53M | $48M | $47M | $49M | $37M | $19M | |
| SG&A Expense | $155M | $121M | $93M | $83M | $88M | $90M | $60M | $40M | $9M | |
| Operating Expenses | · | · | · | · | · | · | $109M | $77M | $28M | |
| Operating Income | $-125M | $-97M | $-66M | $-79M | $-92M | $-127M | $-109M | $-77M | $-20M | |
| Interest Income | $6M | $9M | $3M | $938.0K | $365.0K | $2M | $5M | · | · | |
| Other Non-op | $-670.0K | $-229.0K | $838.0K | $72.0K | $-153.0K | · | $-284.0K | $-124.0K | $12.0K | |
| Pretax Income | $-153M | $-124M | $-98M | $-108M | $-109M | $-125M | $-105M | $-76M | $-20M | |
| Income Tax | $78.0K | $3M | $4M | $2M | $1M | $3M | · | $125.0K | $19.0K | |
| Net Income | $-153M | $-127M | $-102M | $-110M | $-111M | $-128M | $-105M | $-76M | $-20M | |
| EPS (Basic) | $-3.19 | $-2.96 | $-3.55 | $-4.81 | $-4.96 | · | · | · | · | |
| Shares (Basic) | 48,116,098 | 42,876,737 | 28,834,303 | 22,806,812 | 22,347,481 | · | · | · | · | |
| EBITDA | $-125M | · | · | · | $-91M | $-126M | $-109M | $-77M | · |
Bilanz 24
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $172M | $95M | $55M | $44M | $53M | $50M | $101M | $37M | |
| Short-term Investments | $49M | $111M | $56M | · | · | · | · | · | $36M | |
| Receivables | $33M | $20M | $15M | $13M | $12M | $7M | · | · | · | |
| Inventory | $16M | $9M | $6M | $4M | $5M | $2M | · | · | $316.0K | |
| Prepaid Expense | $15M | $9M | $10M | $11M | $7M | $3M | $1M | $672.0K | $958.0K | |
| Current Assets | $186M | $276M | $169M | $129M | $114M | $116M | $149M | $102M | $74M | |
| PP&E (Net) | $637.0K | $655.0K | $689.0K | $1M | $2M | $2M | $977.0K | $948.0K | $805.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | |
| Accum. Depreciation | $5M | $4M | $4M | $3M | $2M | $1M | $998.0K | $747.0K | $577.0K | |
| Other Non-current Assets | $5M | $589.0K | $2M | $3M | $1M | $66.0K | $264.0K | $317.0K | $244.0K | |
| Total Assets | $200M | $286M | $178M | $136M | $120M | $122M | $202M | $104M | $76M | |
| Accounts Payable | $12M | $11M | $7M | $6M | $6M | $3M | $5M | $4M | $3M | |
| Current Liabilities | $46M | $46M | $31M | $24M | $22M | $21M | $19M | $13M | $7M | |
| Capital Leases | $3M | $58.0K | $0 | $2M | $398.0K | $1M | $3M | · | · | |
| Total Liabilities | $306M | $295M | $244M | $225M | $111M | $26M | $22M | $13M | $7M | |
| Long-term Debt | $125M | · | · | · | · | · | · | · | · | |
| Total Debt | $122M | · | · | · | · | · | · | · | · | |
| Common Stock | $133.0K | $115.0K | $89.0K | $63.0K | $61.0K | $60.0K | $57.0K | $44.0K | $37.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | $213M | $116M | |
| Retained Earnings | $-960M | $-806M | $-679M | $-577M | $-467M | $-357M | $-228M | $-123M | $-47M | |
| AOCI | $19.0K | $56.0K | $12.0K | $-107.0K | $-25.0K | $271.0K | $276.0K | · | · | |
| Stockholders' Equity | $-105M | $-9M | $-65M | $-89M | $8M | $96M | $180M | $90M | $69M | |
| Liabilities + Equity | $200M | $286M | $178M | $136M | $120M | $122M | $202M | $104M | $76M | |
| Shares Outstanding | 48,350,272 | 42,231,746 | 32,490,119 | 23,129,953 | 22,462,995 | 22,167,791 | 21,026,184 | 16,214,883 | 13,751,390 |
Cashflow 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $307.0K | $329.0K | $802.0K | $924.0K | $831.0K | $416.0K | $300.0K | $400.0K | $200.0K | |
| Stock-based Comp | $12M | $13M | $9M | $11M | $23M | $28M | $30M | $31M | $6M | |
| Other Non-cash | $-21M | · | · | · | $2M | $-6M | $4M | $7M | · | |
| Operating Cash Flow | $-162M | $-97M | $-76M | $-88M | $-85M | $-106M | $-71M | $-37M | $-10M | |
| CapEx | $289.0K | $295.0K | $194.0K | $254.0K | $752.0K | $1M | $325.0K | $560.0K | $271.0K | |
| Investing Cash Flow | $62M | $-21M | $-953.0K | $1M | $4M | $93M | $-146M | $35M | $-36M | |
| Debt Issued | $0 | $24M | $0 | $96M | $0 | · | · | · | · | |
| Net Debt Issued | $0 | · | · | · | · | · | · | · | · | |
| Stock Issued | $40M | $151M | $67M | $0 | $0 | $16M | $162M | $64M | $61M | |
| Net Stock Activity | $40M | · | · | · | $0 | $16M | $162M | $64M | · | |
| Financing Cash Flow | $40M | $195M | $117M | $97M | $72M | $17M | $165M | $66M | $62M | |
| Net Change in Cash | $-61M | $77M | $40M | $11M | $-9M | $4M | $-51M | $64M | $16M | |
| Taxes Paid | $3M | $2M | · | · | · | · | · | · | · | |
| Free Cash Flow | $-163M | · | · | · | $-86M | $-107M | $-71M | $-38M | · |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 88.7% | · | · | · | 89.3% | 91.5% | 100.0% | -59.8% | · | |
| Operating Margin | -113.7% | · | · | · | -192.1% | -1074.2% | -608211.1% | -6842.2% | · | |
| Net Margin | -139.8% | · | · | · | -230.7% | -1088.9% | -584144.4% | -6707.2% | · | |
| Pretax Margin | -139.7% | · | · | · | -227.7% | -1060.3% | -584144.4% | -6696.1% | · | |
| EBITDA Margin | -113.5% | · | · | · | -190.4% | -1070.8% | -606544.4% | -6806.7% | · | |
| ROA | -63.1% | · | · | · | -91.7% | -79.2% | -68.7% | -84.5% | · | |
| ROE | 154.4% | · | · | · | -554.8% | -118.5% | -53.8% | -78.1% | · | |
| ROIC | -746.5% | · | · | · | -1111.6% | -135.1% | · | -85.8% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | · | · | · | 5.1 | 5.4 | 7.6 | 7.6 | · | |
| Quick Ratio | 4.2 | · | · | · | 2.5 | 2.8 | 2.6 | 7.5 | · | |
| Debt / Equity | -1.2 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -1.2 | · | · | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | · | 0.4 | 0.1 | 0.0 | 0.0 | · | |
| Inventory Turnover | 1.0 | · | · | · | 1.5 | 0.9 | · | · | · | |
| Receivables Turnover | 4.1 | · | · | · | 5.1 | 3.3 | · | · | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.4% | 9.3% | 28.5% | 34.0% | 307.2% | · | · | · | · | |
| Revenue CAGR 3Y | 19.5% | 23.5% | 91.4% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 56.2% | · | · | · | · | · | · | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $110M | $90M | $83M | $64M | $48M | $12M | $18.0K | $1M | · | |
| Net Income TTM | $-153M | $-127M | $-102M | $-110M | $-111M | $-128M | $-105M | $-76M | · | |
| Market Cap | $1.13B | · | · | · | $214M | $399M | $702M | $698M | · | |
| Enterprise Value | $1.09B | · | · | · | · | · | · | · | · | |
| P/S | 10.3 | · | · | · | 4.4 | 33.9 | 38980.2 | 619.0 | · | |
| P/B | -10.7 | · | · | · | 25.4 | 4.1 | 3.9 | 7.7 | · | |
| P / Tangible Book | · | · | · | · | 25.4 | 4.1 | · | · | · | |
| P / Cash Flow | -7.0 | · | · | · | -2.5 | -3.8 | -9.9 | -18.7 | · | |
| P / FCF | -7.0 | · | · | · | -2.5 | -3.7 | -9.8 | -18.4 | · | |
| EV / EBITDA | -8.8 | · | · | · | · | · | · | · | · | |
| EV / FCF | -6.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 10.0 | · | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $51M | $38M | $27M | $24M | $20M | $25M | $25M | $22M | $19M | $24M | $21M | $21M | $17M | $18M | $16M | |
| Cost of Revenue | $7M | $4M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Gross Profit | $66M | $47M | $35M | $24M | $21M | $18M | $22M | $23M | $20M | $17M | $21M | $18M | $19M | $15M | $16M | $14M | |
| R&D Expense | $17M | $16M | $14M | $14M | $19M | $20M | $15M | $11M | $15M | $15M | $11M | $10M | $12M | $12M | $14M | $13M | |
| SG&A Expense | $48M | $51M | $39M | $38M | $43M | $35M | $35M | $29M | $30M | $27M | $25M | $22M | $22M | $24M | $22M | $19M | |
| Operating Income | $111.0K | $-20M | $-19M | $-27M | $-41M | $-37M | $-28M | $-18M | $-26M | $-26M | $-15M | $-14M | $-15M | $-22M | $-20M | $-18M | |
| Interest Income | $946.0K | $931.0K | $908.0K | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $726.0K | $835.0K | $435.0K | $645.0K | $469.0K | $441.0K | |
| Other Non-op | $-347.0K | $-323.0K | $-5.0K | $-197.0K | $-378.0K | $-90.0K | $-62.0K | $-158.0K | $174.0K | $-183.0K | $812.0K | $71.0K | $-30.0K | $-15.0K | $-63.0K | $37.0K | |
| Pretax Income | $-9M | $-28M | $-27M | $-34M | $-49M | $-43M | $-35M | $-24M | $-33M | $-32M | $-22M | $-22M | $-24M | $-30M | $-28M | $-25M | |
| Income Tax | $6M | $-5M | $-275.0K | $-1M | $1M | $392.0K | $3M | $91.0K | $38.0K | $54.0K | $4M | $-9.0K | $54.0K | $21.0K | $689.0K | $709.0K | |
| Net Income | $-14M | $-24M | $-26M | $-33M | $-50M | $-44M | $-38M | $-24M | $-33M | $-32M | $-26M | $-22M | $-24M | $-30M | $-29M | $-26M | |
| EPS (Basic) | $-0.28 | $-0.47 | $-0.53 | $-0.69 | $-1.05 | $-0.92 | $-0.76 | $-0.51 | $-0.82 | $-0.87 | $-0.72 | $-0.68 | $-1.03 | $-1.30 | $-1.25 | $-1.13 | |
| Shares (Basic) | 50,380,112 | 50,182,758 | -95,103,223 | 48,057,386 | 47,739,816 | 47,422,119 | -81,463,401 | 46,779,637 | 40,501,315 | 37,059,186 | 36,153,634 | 32,298,182 | 23,462,016 | 23,279,951 | -45,326,532 | 22,798,263 | |
| EBITDA | $211.0K | $-20M | · | $-27M | $-41M | $-37M | · | $-17M | $-26M | $-26M | · | $-13M | $-15M | $-22M | · | $-18M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $110M | $111M | $90M | $93M | $104M | $172M | $125M | $220M | $131M | $95M | $119M | $20M | $37M | $55M | $29M | |
| Short-term Investments | $30M | $40M | $49M | $64M | $83M | $112M | $111M | $154M | $52M | $52M | $56M | $55M | $36M | $39M | · | · | |
| Receivables | $89M | $55M | $33M | $20M | $20M | $20M | $20M | $23M | $17M | $14M | $15M | $13M | $16M | $12M | $13M | $9M | |
| Inventory | $25M | $21M | $16M | $8M | $7M | $8M | $9M | $8M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $5M | |
| Prepaid Expense | $13M | $20M | $15M | $12M | $12M | $13M | $9M | $14M | $12M | $10M | $10M | $16M | $13M | $12M | $11M | $11M | |
| Current Assets | $235M | $237M | $186M | $169M | $197M | $237M | $276M | $295M | $279M | $197M | $169M | $182M | $81M | $96M | $129M | $122M | |
| PP&E (Net) | $597.0K | $616.0K | $637.0K | $695.0K | $688.0K | $627.0K | $655.0K | $608.0K | $580.0K | $566.0K | $689.0K | $823.0K | $910.0K | $1M | $1M | $2M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | $9M | $7M | $5M | $7M | $801.0K | $371.0K | $589.0K | $370.0K | $673.0K | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Total Assets | $253M | $254M | $200M | $185M | $209M | $248M | $286M | $302M | $282M | $201M | $178M | $194M | $95M | $113M | $136M | $128M | |
| Accounts Payable | $15M | $17M | $12M | $10M | $14M | $15M | $11M | $6M | $8M | $6M | $7M | $4M | $5M | $7M | $6M | $3M | |
| Current Liabilities | $62M | $51M | $46M | $42M | $48M | $42M | $46M | $33M | $34M | $26M | $31M | $26M | $27M | $25M | $24M | $19M | |
| Capital Leases | $2M | $2M | $3M | $3M | $552.0K | $3.0K | $58.0K | $212.0K | $425.0K | $637.0K | $0 | $1M | $1M | $1M | $2M | $2M | |
| Total Liabilities | $385M | $378M | $306M | $300M | $302M | $294M | $295M | $276M | $252M | $241M | $244M | $236M | $234M | $230M | $225M | $192M | |
| Long-term Debt | $200M | $200M | $125M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $189M | $190M | · | $122M | $123M | $122M | · | $122M | $98M | $98M | · | $99M | $98M | $98M | · | $72M | |
| Common Stock | $135.0K | $134.0K | $133.0K | $128.0K | $126.0K | $126.0K | $115.0K | $115.0K | $112.0K | $99.0K | $89.0K | $84.0K | $64.0K | $64.0K | $63.0K | $63.0K | |
| Retained Earnings | $-998M | $-983M | $-960M | $-933M | $-900M | $-850M | $-806M | $-769M | $-745M | $-712M | $-679M | $-653M | $-631M | $-607M | $-577M | $-548M | |
| AOCI | $-2.0K | $8.0K | $19.0K | $23.0K | $6.0K | $14.0K | $56.0K | $236.0K | $-31.0K | $-37.0K | $12.0K | $-134.0K | $-154.0K | $-45.0K | $-107.0K | $-155.0K | |
| Stockholders' Equity | $-132M | $-124M | $-105M | $-115M | $-93M | $-46M | $-9M | $26M | $30M | $-40M | $-65M | $-42M | $-138M | $-117M | $-89M | $-63M | |
| Liabilities + Equity | $253M | $254M | $200M | $185M | $209M | $248M | $286M | $302M | $282M | $201M | $178M | $194M | $95M | $113M | $136M | $128M | |
| Shares Outstanding | 48,869,530 | 48,708,280 | 48,350,272 | 46,781,211 | 46,199,134 | 46,101,785 | 42,231,746 | 42,190,815 | 41,169,954 | 36,127,687 | 32,490,119 | 30,854,778 | 23,498,617 | 23,440,521 | 23,129,953 | 23,011,324 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $100.0K | $75.0K | $35.0K | $100.0K | $100.0K | $72.0K | $6.0K | $100.0K | $100.0K | $123.0K | $185.0K | $200.0K | $200.0K | $217.0K | $309.0K | $200.0K | |
| Stock-based Comp | $5M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $-26M | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-33M | $-45M | $-38M | $-42M | $-40M | $-42M | $-14M | $-28M | $-24M | $-32M | $-13M | $-17M | $-20M | $-26M | $-22M | $-18M | |
| CapEx | $60.0K | $54.0K | $17.0K | $87.0K | $141.0K | $44.0K | $115.0K | $96.0K | $84.0K | $0 | $56.0K | $100.0K | $15.0K | $23.0K | $13.0K | $153.0K | |
| Investing Cash Flow | $2M | $-21M | $28M | $31M | $28M | $-26M | $61M | $-107M | $12M | $14M | $-11M | $401.0K | $4M | $6M | $23M | $-35M | |
| Debt Issued | $0 | $65M | $0 | $0 | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | $0 | $25M | $0 | |
| Net Debt Issued | · | $65M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | $0 | $32M | $8M | $-4.0K | $4.0K | $0 | $15M | $82M | $55M | $0 | $67M | $0 | $0 | $0 | · | |
| Net Stock Activity | · | $0 | · | · | · | $4.0K | · | · | · | $55M | · | · | · | · | · | · | |
| Financing Cash Flow | $500.0K | $65M | $31M | $8M | $296.0K | $34.0K | $71.0K | $40M | $100M | $55M | $40.0K | $116M | $143.0K | $671.0K | $25M | $1M | |
| Net Change in Cash | $-31M | $-800.0K | $21M | $-3M | $-11M | $-68M | $47M | $-95M | $89M | $36M | $-24M | $99M | $-16M | $-19M | $27M | $-52M | |
| Free Cash Flow | · | $-45M | · | · | · | $-42M | · | · | · | $-32M | · | · | · | $-26M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 90.9% | 91.9% | · | 88.1% | 85.3% | 88.5% | · | 90.3% | 89.8% | 90.8% | · | 88.6% | 88.4% | 86.8% | · | 87.5% | |
| Operating Margin | 0.15% | -39.8% | · | -99.7% | -171.2% | -182.3% | · | -69.6% | -118.3% | -137.1% | · | -64.7% | -72.8% | -128.2% | · | -112.4% | |
| Net Margin | -19.8% | -46.3% | · | -121.3% | -206.2% | -216.5% | · | -93.9% | -152.9% | -171.9% | · | -104.9% | -114.2% | -175.7% | · | -160.5% | |
| Pretax Margin | -12.0% | -55.6% | · | -125.2% | -202.0% | -214.5% | · | -93.6% | -152.7% | -171.6% | · | -105.0% | -113.9% | -175.6% | · | -156.1% | |
| EBITDA Margin | 0.29% | -39.6% | · | -99.3% | -170.8% | -181.9% | · | -69.2% | -117.8% | -136.4% | · | -63.8% | -71.8% | -127.0% | · | -111.1% | |
| ROA | -6.2% | -9.4% | · | -13.7% | -20.4% | -19.6% | · | -9.6% | -17.7% | -20.6% | · | -13.6% | -20.0% | -21.7% | · | -19.6% | |
| ROE | 12.7% | 27.6% | · | 74.2% | 158.4% | 101.3% | · | 287.3% | 61.8% | 41.2% | · | 41.6% | 26.9% | 45.2% | · | 162.7% | |
| ROIC | 0.32% | -25.8% | · | -396.1% | -145.2% | -49.2% | · | -12.0% | -20.2% | -44.9% | · | -23.9% | 38.4% | 118.5% | · | -216.7% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.7 | · | 4.0 | 4.1 | 5.6 | · | 9.0 | 8.2 | 7.5 | · | 7.1 | 3.0 | 3.8 | · | 6.4 | |
| Quick Ratio | 3.2 | 4.1 | · | 4.1 | 4.1 | 5.6 | · | 9.2 | 8.5 | 7.5 | · | 7.3 | 2.7 | 3.5 | · | 2.0 | |
| Debt / Equity | -1.4 | -1.5 | · | -1.1 | -1.3 | -2.6 | · | 4.8 | 3.2 | -2.4 | · | -2.3 | -0.7 | -0.8 | · | -1.1 | |
| LT Debt / Equity | -1.4 | -1.5 | · | -1.1 | -1.3 | -2.6 | · | 4.8 | 3.2 | -2.4 | · | -2.3 | -0.7 | -0.8 | · | -1.1 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.3 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.3 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.4 | 1.3 | 1.4 | · | 1.9 | 1.6 | 1.6 | · | 1.9 |
Bewertung (TTM) 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $175M | $123M | · | $97M | $94M | $92M | · | $89M | $85M | $84M | · | $75M | $71M | $63M | · | $58M | |
| Net Income TTM | $-121M | $-151M | · | $-165M | $-155M | $-138M | · | $-115M | $-114M | $-104M | · | $-102M | $-107M | $-111M | · | $-111M | |
| Market Cap | $1.80B | $876M | · | $933M | $633M | $510M | · | $536M | $691M | $542M | · | $432M | $243M | $217M | · | $191M | |
| Enterprise Value | $1.88B | $916M | · | $902M | $579M | $416M | · | $379M | $516M | $456M | · | $356M | $285M | $239M | · | $235M | |
| P/S | 10.3 | 7.1 | · | 9.7 | 6.7 | 5.5 | · | 6.0 | 8.1 | 6.4 | · | 5.7 | 3.4 | 3.4 | · | 3.3 | |
| P/B | -13.6 | -7.0 | · | -8.1 | -6.8 | -11.0 | · | 21.0 | 22.8 | -13.5 | · | -10.3 | -1.8 | -1.9 | · | -3.0 | |
| P / Tangible Book | · | · | · | · | · | · | · | 21.0 | 22.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -19.3 | · | · | · | -12.1 | · | · | · | -17.1 | · | · | · | -8.4 | · | · | |
| P / FCF | · | -19.3 | · | · | · | -12.1 | · | · | · | -17.1 | · | · | · | -8.4 | · | · | |
| EV / EBITDA | 8899.7 | -45.4 | · | -33.0 | -14.0 | -11.3 | · | -21.7 | -20.1 | -17.8 | · | -26.8 | -18.8 | -10.9 | · | -13.1 | |
| EV / FCF | · | -20.2 | · | · | · | -9.9 | · | · | · | -14.4 | · | · | · | -9.2 | · | · | |
| EV / Revenue | 10.7 | 7.4 | · | 9.3 | 6.1 | 4.5 | · | 4.2 | 6.1 | 5.4 | · | 4.7 | 4.0 | 3.8 | · | 4.1 |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $110M | $90M | $83M | $64M | $48M |
| Bruttogewinnmarge % | 88.7% | — | — | — | 89.3% |
| Betriebsgewinnmarge % | -113.7% | — | — | — | -192.1% |
| Nettoergebnis | $-153M | $-127M | $-102M | $-110M | $-111M |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -1.2 | — | — | — | — |
| Liquiditätsgrad | 4.0 | — | — | — | 5.1 |
| Quick Ratio | 4.2 | — | — | — | 2.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-163M | — | — | — | $-86M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 205 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 47 (+16 vs. Vorquartal) | 18 (-8 vs. Vorquartal) | 50 (-4 vs. Vorquartal) | 61 (+18 vs. Vorquartal) | -3.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $167.215.336 | 4.543.895 | 13,70% | Aktien |
| Kynam Capital Management, LP | $89.578.818 | 2.434.207 | 7,34% | Aktien |
| Jefferies Financial Group Inc. | $80.947.194 | 2.199.652 | 6,63% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $62.034.564 | 1.685.719 | 5,08% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $61.581.856 | 1.673.420 | 5,05% | Aktien |
| Point72 Asset Management, L.P. | $56.140.203 | 1.525.549 | 4,60% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $55.514.521 | 1.508.547 | 4,55% | Aktien |
| Opaleye Management Inc. | $52.991.853 | 1.439.996 | 4,34% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $47.912.827 | 1.301.979 | 3,93% | Aktien |
| MENORA MIVTACHIM HOLDINGS LTD. | $42.413.141 | 1.152.531 | 3,48% | Aktien |
| D. E. Shaw & Co., Inc. | $42.166.139 | 1.145.819 | 3,46% | Aktien |
| STATE STREET CORP | $36.913.013 | 1.003.071 | 3,03% | Aktien |
| MPM BIOIMPACT LLC | $34.349.672 | 933.415 | 2,81% | Aktien |
| Soleus Capital Management, L.P. | $30.537.008 | 829.810 | 2,50% | Aktien |
| Migdal Insurance & Financial Holdings Ltd. | $28.369.451 | 770.909 | 2,32% | Aktien |
| GOLDMAN SACHS GROUP INC | $25.868.634 | 702.952 | 2,12% | Aktien |
| ORBIMED ADVISORS LLC | $24.883.682 | 676.187 | 2,04% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $20.199.998 | 548.913 | 1,66% | Aktien |
| Woodline Partners LP | $18.426.717 | 500.726 | 1,51% | Aktien |
| Boxer Capital Management, LLC | $18.400.000 | 500.000 | 1,51% | Aktien |
| BANK OF AMERICA CORP /DE/ | $16.998.031 | 461.903 | 1,39% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16.801.334 | 456.558 | 1,38% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $14.244.323 | 387.074 | 1,17% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $11.063.920 | 300.650 | 0,91% | Aktien |
| ADAR1 Capital Management, LLC | $9.288.136 | 252.395 | 0,76% | Aktien |
| J. Goldman & Co LP | $7.830.120 | 212.775 | 0,64% | Aktien |
| Privium Fund Management B.V. | $7.728.000 | 210.000 | 0,63% | Aktien |
| FMR LLC | $7.251.550 | 197.053 | 0,59% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $7.040.318 | 191.313 | 0,58% | Aktien |
| Parkman Healthcare Partners LLC | $6.405.555 | 174.064 | 0,52% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.531.040 | 150.300 | 0,45% | Kaufoption |
| TWO SIGMA INVESTMENTS, LP | $5.481.838 | 148.963 | 0,45% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.724.016 | 128.370 | 0,39% | Aktien |
| Elmind Capital, LP | $4.416.000 | 120.000 | 0,36% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4.089.989 | 111.141 | 0,34% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.084.800 | 111.000 | 0,33% | Verkaufsoption |
| Aisling Capital Management LP | $3.974.400 | 108.000 | 0,33% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.926.266 | 106.692 | 0,32% | Aktien |
| ARK Investment Management LLC | $3.735.494 | 101.508 | 0,31% | Aktien |
| OAK RIDGE INVESTMENTS LLC | $3.260.149 | 88.591 | 0,27% | Aktien |
| Informed Momentum Co LLC | $2.917.173 | 79.271 | 0,24% | Aktien |
| Swiss National Bank | $2.863.040 | 77.800 | 0,23% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $2.724.083 | 74.024 | 0,22% | Aktien |
| TRUIST FINANCIAL CORP | $2.660.125 | 72.286 | 0,22% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.587.040 | 70.300 | 0,21% | Aktien |
| Ally Bridge Group (NY) LLC | $2.545.934 | 69.183 | 0,21% | Aktien |
| BlackRock, Inc. | $2.066.982 | 56.168 | 0,17% | Aktien |
| RHUMBLINE ADVISERS | $2.021.123 | 54.922 | 0,17% | Aktien |
| CITADEL ADVISORS LLC | $1.865.760 | 50.700 | 0,15% | Kaufoption |
| Atom Investors LP | $1.717.235 | 46.664 | 0,14% | Aktien |
| Bank of New York Mellon Corp | $1.664.133 | 45.221 | 0,14% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.604.443 | 43.599 | 0,13% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.369.218 | 37.207 | 0,11% | Aktien |
| Coastal Bridge Advisors, LLC | $1.361.600 | 37.000 | 0,11% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.353.688 | 36.785 | 0,11% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.289.987 | 35.054 | 0,11% | Aktien |
| J. Goldman & Co LP | $1.251.200 | 34.000 | 0,10% | Kaufoption |
| Focus Partners Wealth | $1.216.645 | 33.061 | 0,10% | Aktien |
| Schonfeld Strategic Advisors LLC | $1.194.491 | 32.459 | 0,10% | Aktien |
| ALGERT GLOBAL LLC | $1.190.480 | 32.350 | 0,10% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.121.260 | 30.469 | 0,09% | Aktien |
| POLEN CAPITAL MANAGEMENT LLC | $1.089.832 | 29.615 | 0,09% | Aktien |
| Cetera Investment Advisers | $1.065.434 | 28.952 | 0,09% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $956.947 | 26.004 | 0,08% | Aktien |
| HighVista Strategies LLC | $918.822 | 24.968 | 0,08% | Aktien |
| MetLife Investment Management, LLC | $915.032 | 24.865 | 0,07% | Aktien |
| Palo Alto Investors LP | $901.600 | 24.500 | 0,07% | Aktien |
| JANE STREET GROUP, LLC | $897.920 | 24.400 | 0,07% | Kaufoption |
| ALLIANCEBERNSTEIN L.P. | $785.906 | 43.710 | 0,06% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $761.613 | 20.696 | 0,06% | Aktien |
| CITIGROUP INC | $743.176 | 20.195 | 0,06% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $718.925 | 19.536 | 0,06% | Aktien |
| JANE STREET GROUP, LLC | $717.600 | 19.500 | 0,06% | Verkaufsoption |
| Susquehanna Portfolio Strategies, LLC | $714.067 | 19.404 | 0,06% | Aktien |
| XTX Topco Ltd | $713.405 | 19.386 | 0,06% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $696.725 | 38.750 | 0,06% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $677.046 | 18.398 | 0,06% | Aktien |
| Quantinno Capital Management LP | $671.674 | 18.252 | 0,06% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $647.128 | 17.585 | 0,05% | Aktien |
| GLENMEDE TRUST CO NA | $633.180 | 17.206 | 0,05% | Aktien |
| Toroso Investments, LLC | $631.684 | 26.972 | 0,05% | Aktien |
| Invesco Ltd. | $624.238 | 16.963 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $610.880 | 16.600 | 0,05% | Verkaufsoption |
| Birchview Capital, LP | $606.722 | 16.487 | 0,05% | Aktien |
| Engineers Gate Manager LP | $602.710 | 16.378 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $579.122 | 15.737 | 0,05% | Aktien |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | $566.131 | 15.384 | 0,05% | Aktien |
| LPL Financial LLC | $532.018 | 14.457 | 0,04% | Aktien |
| Verdad Advisers, LP | $531.392 | 14.440 | 0,04% | Aktien |
| MML INVESTORS SERVICES, LLC | $527.160 | 14.325 | 0,04% | Aktien |
| MAI Capital Management | $516.304 | 14.030 | 0,04% | Aktien |
| CITADEL ADVISORS LLC | $477.848 | 12.985 | 0,04% | Aktien |
| DNB Asset Management AS | $474.941 | 12.906 | 0,04% | Aktien |
| State of New Jersey Common Pension Fund D | $463.422 | 12.593 | 0,04% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $462.429 | 12.566 | 0,04% | Aktien |
| Integrated Wealth Concepts LLC | $432.071 | 11.741 | 0,04% | Aktien |
| Arax Advisory Partners | $431.996 | 11.739 | 0,04% | Aktien |
| Squarepoint Ops LLC | $430.523 | 11.699 | 0,04% | Aktien |
| WOLVERINE TRADING, LLC | $415.338 | 21.700 | 0,03% | Kaufoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $412.050 | 11.197 | 0,03% | Aktien |
Unternehmensinsider 17 Insider · 6 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dong Kim | Chief Financial Officer | 25. März 2022 A | — | 0 | 0 | $0 |
| Molly Henderson | Chief Financial Officer | 31. Januar 2022 A | 5.248 | 0 | 0 | $0 |
| Peter P. Pfreundschuh | Chief Financial Officer | 15. Oktober 2020 M | 10.405 | 0 | 0 | $0 |
| Stephen Mullennix | Chief Operating Officer | 26. April 2020 M | 10.084 | 0 | 0 | $0 |
| Mark Schoenberg | Chief Medical Officer | 22. Juni 2026 S | 129.763 | 0 | 2 | $-492.661 |
| Jason Drew Smith | General Counsel | 31. Januar 2022 A | 7.449 | 0 | 0 | $0 |
| Daniel George Wildman | Direktor | 22. Juni 2026 A | — | 0 | 0 | $0 |
| Leana Wen | Direktor | 22. Juni 2026 A | — | 0 | 0 | $0 |
| Stuart Holden | Direktor | 22. Juni 2026 A | — | 0 | 0 | $0 |
| James A. Robinson Jr. | Direktor | 22. Juni 2026 A | — | 0 | 0 | $0 |
| Arie Belldegrun | Direktor | 22. Juni 2026 A | 245.452 | 0 | 0 | $0 |
| Cynthia M Butitta | Direktor | 22. Juni 2026 A | — | 0 | 0 | $0 |
| Shawn Tomasello | Direktor | 7. Juni 2021 A | — | 0 | 0 | $0 |
| Fred Cohen | Direktor | 7. Juni 2021 A | 15.000 | 0 | 0 | $0 |
| Kathryn E Falberg | Direktor | 7. Juni 2021 A | — | 0 | 0 | $0 |
| Ran Nussbaum | Direktor | 25. März 2021 M | 1.431.717 | 0 | 0 | $0 |
| Elizabeth A. Barrett | — | 31. Januar 2022 A | 308.358 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Monograph Capital Partners I, L.P., Monograph Capital Partners I GenPar, LP, Monograph Capital Holdings Advisors, LLC, Fred Cohen, Charles Conn ×2 Einreichungen | 9. Juni 2025 | 1,90% | Änderung | — | SEC |
| Pontifax Management III G.P. (2011) Ltd., Pontifax Management Fund III L.P., Pontifax (Cayman) III, L.P., Pontifax (Israel) III, L.P. ×2 Einreichungen | 18. November 2024 | — | Erste Einreichung | — | SEC |
| Arkin Communications Ltd., Moshe Arkin ×5 Einreichungen | 22. Februar 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 18 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,44% | 144.513 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 2.650 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,13% | 281.502 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,10% | 331.197 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 46.360 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 39.426 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,06% | 1.085.493 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 245.185 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,03% | 30.883 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 17.462 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 117.009 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 55.730 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 2.395 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.082 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.318 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 15.228 SH | 8. August 2026 | Täglich |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 163 NS | 31. Mai 2026 | N-PORT |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.496 SH | 8. August 2026 | Täglich |